Publications

  1. Obadawo, B. S.; Halicki, P. C. B.; Becker, K. L.; Seeliger, J. C.; Rohde, K. H.; Sucheck, S. J. Discovery of 2,4,5-Substituted Benzoxazole Derivatives as Pks13 Inhibitors with Antimycobacterial Activity. ACS Infect. Dis., submitted.

  2. Ubeysinghe, S.; Sebilleau, C.; Thotamune, W.; Rajarathna, C.; Azibere, S.; Tennakoon, M.; Payton, J.; Sprague, R.; Martin, S.; Sucheck, S.; Karunarathne, A. Recombinant-Chemosynthetic Biosensors for Probing Cell Surface Signaling of RBCs and Other Cells. Chem. Biomed. Imaging, 2025, Just Accepted

  3. Sebilleau, C. O., & Sucheck, S. J. Lipopeptide adjuvants for antibiotics and vaccines: The future step in the fight against multidrug-resistant and extensively drug-resistant pathogens. Explor. Drug. Sci., 2024, 2, 203–233. https://doi.org/10.37349/eds.2024.00043

  4. Thanvi, R.; Nada, S.; Dissanayake, R.; Vartak, A.; Sebilleau, C. O.; Alom, N.-E.; Prestwich, E. G.; Wall, K. A. ; Sucheck, S. J. Synthesis and Evaluation of a Self-Adjuvanting Pseudomonal Vaccine Based on Major Outer Membrane Porin OprF Epitopes Formulated with Low-Toxicity QS-21-Containing Liposomes. Bioconj. Chem. 2023, 34, 893-910. DOI: 10.1021/acs.bioconjchem.3c00103

  5. Johnstone, M. A. Si, A.; Landgraf, A. D.; Sucheck, S. J.; Self. W. T. Evaluation of Derivatives of (+)-Puupehenone against Clostridioides difficile and Other Gram-Positive Bacteria. 2022 7, 27155–27163. https://doi.org/10.1021/acsomega.2c04471.

  6. Thanvi, R.; Jayasinghe, T. D.; Sunayana, K.; Obadawo1, B.S.; Ronning, D.R.; and Sucheck, S.J. Synthesis of C7/C8-cyclitols and C7N-aminocyclitols from maltose and X-ray Structure of a Streptomyces coelicolor GlgEI V279S in complex with an Amylostatin GXG-like derivative. Front. Chem. 2022, https://doi.org/10.3389/fchem.2022.950433.

  7. Si, A.; Landgraf, A. D.; Sucheck, S. J.; Rohde, K.H. Synthesis and evaluation of marine natural product-inspired meroterpenoids with selective activity towards dormant Mycobacterium tuberculosis ACS Omega 2022, 7, 23487–23496. https://doi.org/10.1021/acsomega.2c01887

  8. Si, A. and Sucheck, S. J. Synthesis of aminooxy glycoside derivatives of the outer core domain of Pseudomonas aeruginosa lipopolysaccharide. Front. Mol. Biosci. 2021, 8, e750502. PMCID: PMC8606414; PMID: 34820424; doi: 10.3389/fmolb.2021.750502

  9. Khan, S. S.; Sudasinghe, T. D.; Landgraf, A. D.; Ronning, D. R.; Sucheck, S. J. Total synthesis of tetrahydrolipstatin, its derivatives, and evaluation of their ability to potentiate multiple antibiotic classes against Mycobacterium species. ACS Infect. Dis. 2021, 7, 2876–2888; PMID: 34478259 PMCID: PMC8630808; doi: 10.1021/acsinfecdis.1c00283

  10. Si, A.; Jayasinghe, T.D.; Thanvi, R.; Ronning, D. R.; Sucheck, S. J. Stereoselective synthesis of a 4-⍺-glucoside of valienamine and its X-ray structure in complex with Streptomyces coelicolor GlgE1-V279S. Sci. Rep. 2021, 11, 13413. https://doi.org/10.1038/s41598-021-92554-9

  11. Landgraf, A. D.; Alsegiani, A. S.; Alaqel, S.; Thanna, S.; Shah Z. A.; Sucheck, S. J. Neuroprotective and anti-neuroinflammatory properties of ebselen derivatives and their potential to inhibit neurodegeneration. ACS Chem Neurosci. 2020, doi.org/10.1021/acschemneuro.0c00328

  12. Hossain, M. K.; Vartak, A.; Sucheck, S. J; Wall K.A. Synthesis and Immunological Evaluation of a Single Molecular Construct MUC1 Vaccine Containing L-Rhamnose Repeating Units. Molecules 2020, 25, 3137-3146. doi.org/10.3390/molecules25143137

  13. Thanvi, R.; Kapil S.; and Sucheck, S. J. Strategies for Developing Carbohydrates as Glycoside Hydrolase Inhibitors. In Carbohydrate Chemistry: Chemical and Biological Approaches Volume 44; A. P. Rauter, T. K. Lindhorst, Y. Queneau, Eds.; Specialist Periodical Reports; Royal Society of Chemistry: Croydon, United Kingdom; 2020; pp207-227. ISBN: 978-1-78801-368-0; https://doi.org/10.1039/9781788013864-00207

  14. Nandedkar-Kulkarni, N.; Vartak, A.; Sucheck, S. J.; Wall, K.; Quinn, A.; Morran, M.; McInerney, M. Development of a bioconjugate platform for modifying the immune response of autoreactive cytotoxic T lymphocytes involved in type 1 diabetes. Bioconj. Chem. 2019, 30, 2049–2059 doi: 10.1021/acs.bioconjchem.9b00332

  15. Vartak, A.; Goins, C.; Nogueira de Moura, V. C.; Schreidah, C. M.; Landgraf, A. D.; Lin B.; Du, J.; Jackson, M.; Ronning D. R.; Sucheck S. J. Biochemical and microbiological evaluation of N-aryl urea derivatives against Mycobacteria and Mycobacterial hydrolases. MedChemComm, 2019, 10, 1197–1204, PMID: 31741730; PMCID: PMC6677023; doi: 10.1039/C9MD00122K

  16. Hossain, M. K.; Vartak, A.; Sucheck, S. J; Wall. K.A. A liposomal Fc domain conjugated to a cancer vaccine enhances both humoral and cellular immunity. ACS Omega, 2019, 4, 5204–5208. PMCID: PMC6441943, doi: 10.1021/acsomega.9b00029.

  17. Kapil, S.; Petit, C.; Drago, V. N.; Ronning, D. R.; Sucheck, S. J. Synthesis and in vitro characterization of trehalose‐based inhibitors of mycobacterial trehalose 6‐phosphate phosphatases. ChemBiochem 2019, 20, 260–269. PMCID: PMC6467533. doi: 10.1002/cbic.201800551

  18. Vartak, A.; Thanna, S.; Meyer, K.; Dermanelian, M.; Sucheck, S. J. Oligosaccharide synthesis on soluble high-molecular weight pHEMA using a photo-cleavable linker. RSC Adv., 2018, 8, 41612–41619. NIHMSID: 1026069, doi: 10.1039/C8RA08252A

  19. Hossain, M. K.; Vartak, A.; Karmakar, P.; Sucheck, S. J. and K. A. Wall. Augmenting vaccine immunogenicity through the use of natural human anti-rhamnose antibodies. ACS Chem. Biol. 2018, 13, 2130–2142. PMCID: PMC6103300, doi: 10.1021/acschembio.8b00312.

  20. Vartak, A. and Sucheck, S. J. Advances in synthetic approaches towards glycoantigens. In Carbohydrate-Based Vaccines: From Concept to Clinic; A. Krishna Prasad, Ed.; ACS Symposium Series 1290; American Chemical Society: Washington, DC, 2018; pp175-195; ISBN13: 9780841233379; doi: 10.1021/bk-2018-1290.ch008

  21. Vartak, A.; Hefny, F. M.; Sucheck, S. J. Synthesis of Oligosaccharide components of the outer core domain of P. aeruginosa lipopolysaccharide using a multifunctional hydroquinone-derived reducing-end capping group. Org. Lett. 2018, 20, 353−356. PMCID: PMC6169316, doi:10.1021/acs.orglett.7b03590

  22. Veleti S. K. and Sucheck, S. J. Glycoconjugate-based inhibitors of Mycobacterium tuberculosis GlgE. In Glycoconjugate-based inhibitors of Mycobacterium tuberculosis GlgE; Witczak, Z. J., Bielski, R., Eds.; Wiley: New Jersey, 2017. pp91-107. ISBN 978-3-319-65587-1

  23. Veleti, S. K.; Petit, C.; Ronning, D. R.; Sucheck, S. J. Zwitterionic pyrrolidene-phosphonates: inhibitors of the glycoside hydrolase-like phosphorylase Streptomyces coelicolor GlgEI-V279S Org. Biomol. Chem., 2017, 15, 3884–3891. doi: 10.1039/C7OB00388A (Hot Article) PMID: 28422240. Author Correction: Veleti, S. K.; Petit, C.; Lindenberger, J. J.; Ronning, D. R.; Sucheck, S. J. Org. Biomol. Chem., doi: 10.1039/C7OB90121F

  24. Goins, C. M.; Thanna, S, Dajnowicz, S.; Sucheck, S. J.; Parks, J. M.; Ronning, D. R. Exploring covalent allosteric inhibition of Antigen 85C from Mycobacterium tuberculosis by ebselen derivatives. ACS Infect. Dis., 2017, 3, 378–387. doi: 10.1021/acsinfecdis.7b00003 PMID: 28285521

  25. Thanna, S.; Goins, C. M.; Knudson, S. E.; Slayden, R. A.; Ronning, D. R; Sucheck S. J. Thermal and photoinduced copper-promoted C−Se bond formation: Synthesis of 2-alkyl-1,2-benzisoselenazol-3(2H)ones and evaluation against Mycobacterium tuberculosis J. J. Org. Chem., 2017, 82, 3844–3854. doi: 10.1021/acs.joc.7b00440 PMID: 28273423

  26. Sucheck, S. J. Domino and intramolecular rearrangement reactions as advanced synthetic methods in glycosciences. Eds Z. J. Witczak and R. Bielski. Angew. Chem. Int. Ed. 2016, 55, 11337–11338. Book Review. doi: 10.1002/anie.201606642

  27. Thanna, S.; Knudson, S. E.; Grezegorzewic, A.; Kapil, S.; Goins, C. M.; Ronning, D. R.; Jackson, M.; Slayden, R. A. Sucheck, S. J. Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis Org. Biomol. Chem., 2016, 14, 6119–6133. PMID: 27251120; PMCID: PMC4918453 doi: 10.1039/C6OB00821F.

  28. Vartak, A. and Sucheck, S. J. Recent advances in subunit vaccine carriers. Vaccines (Basel) 2016, 4, pii: E12. doi: 10.3390/vaccines4020012. PMCID: PMC4931629, PMID: 27104575

  29. Thanna, S. and Sucheck S. J. Targeting the trehalose utilization pathways of Mycobacterium tuberculosis. Med. Chem. Commun., 2016, 7, 69–85. doi: 10.1039/C5MD00376H. PMID: 26941930

  30. Karmakar, P.; Lee, K.; Sarkar, S.; Wall, K. A.; Sucheck, S. J. Synthesis of a liposomal MUC1 glycopeptide-based immunotherapeutic and evaluation of the effect of L-rhamnose targeting on cellular immune responses. Bioconj. Chem. 2016, 27, 110–20. PMCID: PMC4837471 doi: 10.1021/acs.bioconjchem.5b00528

  31. Lindenberger, J. J; Veleti, S. K.; Wilson, B.; Sucheck, S. J.; Ronning, D. R. Crystal structures of Mycobacterium tuberculosis GlgE and complexes with noncovalent inhibitors. Sci. Reports. 2015, 5, 12830. doi: 10.1038/srep12830. PMID: 26245983

  32. Giatonde, V. and Sucheck, S. J. Anti-tuberculosis drugs based on carbohydrate derivatives. In Carbohydrates Chemistry: State-of-the-art and challenges for drug development; Cipolla, L., Ed.; Imperial College Press: London, Aug 12, 2015. ISBN-10: 1783267194; ISBN-13: 978-1783267194.

  33. Thanna, S.; Lindenberger, J. J.; Vishwanath, G.; Ronning, D. R.; Sucheck, S. J. Synthesis of 2-deoxy-2,2-difluoro-α-maltosyl fluoride and its X-ray structure in complex with Streptomyces coelicolor GlgEI-V279S. Org. Biomol. Chem. 2015, 13, 7542–7550. doi: 10.1039/c5ob00867k. PMID: 26072729

  34. Veleti, S. K.; Lindenberger, J. J.; Thanna, S.; Ronning, D. R.; Sucheck, S. J. Synthesis of a poly-hydroxypyrolidine-based inhibitor of Mycobacterium tuberculosis GlgE. J. Org. Chem. 2014, 79, 9444–9450. PMID:25137149 (Feature Article)

  35. Long, D. E.; Karmakar P.; Wall, K. A.; Sucheck, S. J. Synthesis of α-L-rhamnosyl ceramide and evaluation of its binding with anti-rhamnose antibodies. Bioorg. Med. Chem. 2014, 22, 5279–89. PMCID:PMC4172545 doi: 10.1016/j.bmc.2014.08.002

  36. Bouhall S. K and Sucheck, S. J. In situ preactivation strategies for the expeditious synthesis of oligosaccharides: A review. J. Carbohydr. Chem. 2014, 33, 347–367. PMID: 25328276

  37. Gaitonde, V.; Lee, K.; Kirschbaum, K.; Sucheck S. J. Bio-based bisfuran: synthesis, crystal structure, and low molecular weight amorphous polyester. Tetrahedron Lett. 2014, 55, 4141–4145. PMCID:PMC4096679

  38. Veleti, S. K.; Lindenberger, J. J.; Ronning, D. R.; Sucheck S. J. Synthesis of a C-phosphonate mimic of maltose-1-phosphate and inhibition studies on Mycobacterium tuberculosis GlgE. Bioorg. Med. Chem. 2014, 22, 1404–1411. PMCID:PMC4023634

  39. Sarkar, S.; Sayler, A. C. D.; Wall, K. A.; Sucheck, S. J. Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into L-rhamnose displaying liposomes. Bioconj. Chem. 2013, 24, 363–375. PMCID: PMC3623543

  40. Ibrahim, D. A.; Boucau, J.; Lajiness, D. H.; Veleti, S. K.; Trabbic, K. R.; Adams, S. S.; Ronning, D. R.; Sucheck S. J. Design, synthesis and X-ray analysis of a glycoconjugate bound to Mycobacterium tuberculosis Antigen 85C. Bioconj. Chem. 2012, 23, 2403–2416. PMCID: PMC3548330

  41. Gaitonde, V. and Sucheck S. J. Synthesis of β-Glycosyl amides from N-glycosyl dinitrobenzenesulfonamides J. Carbohydr. Chem. 2012, 31, 433–450. PMCID:PMC3551597

  42. Karmakar, P.; Talan, S. R.; Sucheck, S. J. Mixed-phase synthesis of glycopeptides using a N-peptidyl-2,4-dinitrobenzenesulfonamide-thioacid ligation strategy. Org. Lett. 2011, 13, 5298–5301. PMCID: PMC3188410

  43. Sarkar, S.; Sucheck S. J. Comparing the use of 2-methylenenapthyl, 4-methoxybenzyl, 3,4-dimethoxybenzyl and 2,4,6-trimethoxybenzyl as N–H protecting groups for p-tolyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-1-thio-β-D-glucosides. Carbohydr. Res. 2011, 346, 393–400.

  44. Sarkar, S.; Lombardo, S. A.; Herner, D. N.; Talan, R. S.; Wall, K. A.; Sucheck S. J. Synthesis of a single molecule L-rhamnose-containing three component vaccine and evaluation of antigenicity in the presence of anti L-rhamnose antibodies. J. Am. Chem. Soc. 2010, 132, 17236–17246.

  45. Umesiri, F. E.; Sanki, A. K.; Boucau, J.; Ronning, D. R.; Sucheck, S. J. Recent advances towards the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis. Med. Res. Rev. 2010, 30, 290–326. doi: 10.1002/med.20190. PMID: 20099253

  46. Talan, R. S.; Sanki, A. K.; Sucheck, S. J. Facile synthesis of N-glycosyl amides using a N-glycosyl-2,4-dinitrobenzenesulfonamide and thioacids. Carbohydr. Res. 2009, 344, 2048–2050.

  47. Sanki, A. K.; Boucau, J.; Umesiri, F. E.; Ronning, D. R.; Sucheck, S. J. Design, synthesis and biological evaluation of sugar-derived esters, α-ketoesters and α-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C. Mol. BioSyst. 2009, 5, 945–956. doi: 10.1039/b902284h. PMID: 19668859

  48. Ragupathi, G.; Damani, P.; Srivastava, G.; Srivastava, O.; Sucheck, S. J.; Ichikawa, Y.; Livingston, P. O. Synthesis of sialyl Lewisa (sLea, CA19-9) and construction of an immunogenic sLea vaccine. Cancer Immunol. Immunother. 2009, 58, 1397–1405.

  49. Sanki, A. K.; Talan, R. S.; Sucheck, S. J. Synthesis of small glycopeptides by decarboxylative condensation and insight into the reaction mechanism. J. Org. Chem. 2009, 74, 1886–1896.

  50. Sanki, A. K.; Boucau, J.; Ronning, D. R.; Sucheck, S. J. Antigen 85C-mediated acyl-transfer between synthetic acyl donors and fragments of the arabinan. Glycoconjugate J. 2009, 26, 589–596. doi: 10.1007/s10719-008-9211-z. PMID: 19052863

  51. Boucau J.; Sanki, A. K.; Voss, B. J.; Sucheck, S. J.; Ronning D. R. A coupled assay measuring Mycobacterium tuberculosis antigen 85C enzymatic activity. Anal. Biochem. 2009, 385, 120–127. doi: 10.1016/j.ab.2008.10.018. PMID: 18992216

  52. Sanki A. K.; Boucau J.; Srivastava P.; Adams S. S.; Ronning, D. R., Sucheck, S. J Synthesis of methyl 5-S-alkyl-5-thio-arabinofuranosides and evaluation of their antimycobacterial activity. Bioorg. Med. Chem. 2008, 16, 5672–5682. doi: 10.1016/j.bmc.2008.03.062. PMID: 18450455

  53. Demaray, J. A.; Thuener, J. E.; Dawson, M. N.; Sucheck, S. J. Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity. Bioorg. Med. Chem. Lett. 2008, 18, 4868–4871. doi: 10.1016/j.bmcl.2008.07.087. PMID: 18678487

  54. Liang, C. -H; Romero, A.; Rabuka, D.; Sgarbi, P. W. M.; Marby, K. A.; Duffield, J.; Yao, S.; Cheng, M. L; Ichikawa, Y.; Sears, P.; Hu, C.; Hwang, S.-B.; Shue, Y.-K.; Sucheck, S. J. Structure–activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities. Bioorg. Med. Chem. Lett. 2005, 15, 2123–2128. PMID: 15808482

  55. Romero, A.; Liang, C. -H.; Chiu, Y. -H.; Yao, S.; Duffield, J.; Sucheck, S. J.; Marby, K.; Rabuka, D.; Leung, P. Y.; Shue, Y. -K.; Ichikawa, Y.; Hwang, C. -K. An efficient entry to new sugar modified ketolide antibiotics. Tet. Lett. 2005, 46, 1483–1487.

  56. Yao, S.; Sgarbi, P. W. M.; Marby, K. A.; Rabuka, D.; O’Hare, S. M.; Cheng, M. L.; Bairi, M.; Hu, C.; Hwang, S.-B.; Hwang, C.-K.; Ichikawa, Y.; Sears, P.; Sucheck, S. J. Glyco-optimization of aminoglycosides: new aminoglycosides as novel anti-infective agents. Bioorg. Med. Chem. Lett. 2004, 14, 3733–3738. PMID: 15203152

  57. Lee, L. V.; Bower, K. E.; Liang, F. S.; Shi, J.; Wu, D.; Sucheck, S. J.; Vogt, P.K.; Wong, C.-H. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides. J. Am. Chem. Soc. 2004; 126, 4774–4775.

  58. Agnelli, F.; Sucheck, S. J.; Marby, K. A; Rabuka, D.; S. -L., Yao; Sears, P. S.; Liang, F.-S.; Wong, C. -H. Dimeric aminoglycosides as antibiotics. Angew. Chem. Int. Ed. 2004, 43, 1562–1566. PMID: 15022234

  59. Sucheck, S. J. and Shue, Y.-K. Combinatorial synthesis of aminoglycoside libraries. Curr. Opin. Drug Discovery and Development 2001, 4, 462–470.

  60. Sucheck, S. J.; Wong, C.-H. RNA as a target for small molecules. Curr. Opin. Chem. Biol. 2000, 4, 678–686.

  61. Sucheck, S. J.; Wong, A. L.; Koeller, K. M.; Boehr, D. D.; Draker, K.-A.; Sears, P.; Wright, G. D.; Wong, C.-H. Design of bifunctional antibiotics that target bacterial rRNA and inhibit resistance-causing enzymes. J. Am. Chem. Soc. 2000, 122, 5230–5231.

  62. Sucheck, S. J.; Greenberg, W. A.; Tolbert, T., Wong, C.-H. Design of small molecules that recognize RNA: Development of aminoglycosides as potential antitumor agents that target oncogenic RNA sequences. Angew. Chem., Int. Ed. 2000, 39, 1080–1084.

  63. Cagir, A.; Tao, Z.-F.; Sucheck, S. J.; Hecht, S. M. Solid phase synthesis and biochemical evaluation of conformationally constrained analogues of deglycobleomycin A5 Bioorganic Med. Chem. Lett. 2003, 11, 5179–5187.

  64. Sucheck, S. J. Study of naturally occurring nucleic acid interactive agents. 1998, 205 pp.

  65. Chen, J.; Zhang, Y.-H., Wang, L.-K.; Sucheck, S. J.; Snow, A. M.; Hecht, S. M. Inhibitors of DNA polymerase β from Schoepfia Californica. Chem. Commun. 1998, 2769–2770.

  66. Katono, K.; An, H.; Aoyagi, Y. Overhand, M.; Sucheck, S. J.; Stevens, W. C. Jr.; Hess, C. D.; Zhou, X.; Hecht, S. M. Total synthesis of bleomycin group antibiotics. The total synthesis of bleomycin demethyl A2, bleomycin A2 and decarbamoyl bleomycin demethyl A2. J. Am. Chem. Soc. 1998, 120, 11285–11296.

  67. Sucheck, S. J.; Ellena, J. F.; Hecht, S. M. Characterization of Zn(II).deglycobleomycin A2 and interaction with d(CGCATGCG)2. Direct evidence for minor groove binding of the bithiazole moiety. J. Am. Chem. Soc. 1998, 120, 7450–7460.

  68. Skrzypczak-Jankun, E., Sucheck, S., Smith, D.A. 4-Methyl-3,5-dioxopiperazine acetic acid and 4-methyl-3,5-dioxopiperazine-N-methylacetic amide. Cambridge Crystallographic Data Centre, deposition no. CCDC 118966/CCDC 118967, 1999.

  69. Smith, D. A., Sucheck, S.; Cramer, S.; Baker, D. Nitrilotriacetamide: Synthesis in concentrated sulfuric acid and stability in water Synth. Commun. 1995, 25, 4123–4132.

  70. Cramer, S.; Sucheck, S. J.; Skrzypczak-Jankun, E.; Smith, D. A. Facile synthesis of substituted nitrilotriacetamides. Tetrahedron Lett. 1992, 33, 7765–7768.

  71. Sucheck, S. J.; Pinkerton, A. A.; Smith, D. A. Characterization of [Pb(NO3)(ntam)2]NO3 the first metal complex of the neutral tetradentate ligand nitrilotriacetamide (ntam). J. Chem. Soc., Chem. Commun. 1992, 367–368.

Patents and Patent Applications

  1. UT Docket D2022-26; University of Central Florida Attorney Docket: 10669-389US0 Antimicrobial Compositions and Uses for Treatment of Clostridioides difficile, Mycobacterium tuberculosis, and Enterococcus faecalis Infection. Steven J. Sucheck, William T. Self. Kyle H. Rohde, Anshupriya Si, Alexander Landgraf, Sandra Geden, Michael Johnstone Filed: 5-06-2022

  2. UT Docket D2019-03 Compositions and Methods for Organic Synthesis of Polysaccharides using poly(2-hydroxyethylmethylacrylate) (pHEMA). S. J. Sucheck and A. R. Vartak Provisional Patent Appln. Filed: 7-11-2018.

  3. UT Docket D2017-06 Synthetic lipopeptide vaccines and immunotherapeutics. A. R. Vartak, S. J. Sucheck, K. A. Wall, A. Quinn, M. F. Mcinerney. International Application No.: PCT/US2017/053359; International Filing Date: 26.09.2017; Pub. No.: WO/2018/058086; Publication Date: March 29, 2018 Patent: US11007256B2, 2021-05-18

  4. UT Docket D2015-17 Substituted Isoselenazolone Anti-Infective, Anti-Inflammatory, Anti-Cancer, Cytoprotective, Neuroprotective, and Anti-Oxidant Agents. Sucheck, S. J; Thanna, S.; Ronning, D.; Landgraf, A. Provisional Patent Appln. US Serial No.: 62/352,712 Filed: 6-21-2016; PCT/US17/38467 Filed: 6-21-2017. PCT Int. Appl. (Dec 28, 2017), WO 2017223160 A1 20171228 Patent: US11053236B2, 2021-07-06

  5. UT Docket D2016-53 Anti-Infective 2-Aminothiophenes. Inventors: Sucheck, S. J; Thanna, S.; Slayden R. Provisional Patent Appln. US Serial No.: 62/325,755 Filed: 4-21-2016. PCT/US17/28782; Filed: 4-21-2017. PCT Int. Appl. (Oct 26, 2017), WO 2017184947 A1 20171026; US 2019/0119296 A1 Apr. 25, 2019. Patent: US10647725B2, 2020-05-12

  6. UT Docket D2014-20: Amorphous Polyester from Bio-Based Bis-Furan Assembly. Inventors: Giatonde, V.; Sucheck, S. J. M. Coleman Patent: US 9527952 B1. Dec 27, 2016.

  7. UT Docket D2012-01: Methods for forming peptides and peptide conjugates and peptides and peptide conjugates compositions formed thereby. Inventors: Talan, R. S.; Karmakar, P.; Sucheck, S. J. US Patent: US 8,895,869 B1 Nov 25, 2014.

  8. UT Docket D2012-14: PCT Application. Xeno-antigen-Displaying Anti-Cancer Vaccines and Method of Making. Inventors: Sucheck, S. J.; Wall, K. A.; Sarkar, S. PCT Application No. PCT/US13/026271. Filed: 2-15-2013. US 14/378,805 Filed 8-14-2014. Patent: AU 2013221448 June 8, 2017; US 10206988B2 Feb. 19, 2019.

  9. Bifunctional Antibiotics. Sucheck, S. J. and Wong, C.-H. U.S. Patent 6,921,818. Filed: 07-26-2005.

  10. Processes for the preparation of glycoconjugates of the breast cancer antigen Globo-H. O. Srivastava, O.; Srivastava, G.; Liang, C.-H; Yao, S.; Rabuka, D.; Wacowich-Scarbi, S.A.; Sucheck S. J.; Ichikawa. Y. 60/655,311. Filed: 02-22-2005.

  11. Antibacterial Agents. Liang, C.-H.; Duffield, J.; Romero, A.; Chiu, Y.-H.; Rabuka, D.; Yao, S., Sucheck, S. J.; Marby, K. A.; Shue, Y.-K.; Ichikawa, Y.; Hwang, C.-K. Patent 2013-12-26, 2013-12-26; US20130345410A1 US9200026B2, 2015-12-01

  12. New aminoglycoside antibiotics as novel anti-infective agents. Liang, C.-H.; Marby, K. A.; Rabuka, D.; Romero, A.; Sgarbi, P. W. M.; Sucheck, S. J.; Shue Y.-K; Yao S. U.S. Patent 10/606,700. Filed: 06-26-2003.